Month: March 2022

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. MONTREAL, March 28, 2022 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) is pleased to announce that it has received shareholder approval by written resolution for the private placement announced on March 16, 2022. The terms of the private placement, as announced in the March 16 press releases, and the process for obtaining shareholder approval are described below. The Corporation intends to complete a brokered private placement for the issuance and sale of 20,000,000 units of the Corporation (the “Units”) at a price of $0.60 per Unit (the “Subscription Price”), for aggregate gross proceeds of...

MONACO, March 28, 2022 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company” or “our”) (NYSE: CMRE) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2021 (the “Annual Report”) has been filed with the U.S. Securities and Exchange Commission and can be accessed on the Company’s website, www.costamare.com, in the “Investors” section under “Annual Reports”. Stockholders may also request a hard copy of the Annual Report, which includes the Company’s complete 2021 audited financial statements, free of charge, by contacting the Company’s investor relations manager at ir@costamare.com. About Costamare Inc. Costamare Inc. is one of the world’s leading owners and providers of containerships for charter. The Company has 48 years of history in the international shipping industry and a fleet of 82 containerships,...

Bagsværd, Denmark, 28 March 2022 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a 2.0 mg dose of Ozempic® (once-weekly semaglutide subcutaneous injection), a glucagon-like peptide-1 (GLP-1) analogue for the treatment of adults with type 2 diabetes. Ozempic® is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults. Further, Ozempic® is indicated to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes and known heart disease. The FDA approval is based on the results from the SUSTAIN FORTE trial. In the trial, people treated with semaglutide 2.0 mg achieved a statistically significant and superior reduction in HbA1c at week 40 compared to semaglutide 1.0 mg. In the trial, both doses of...

Conference Call Scheduled for Thursday, March 31, 2022 at 9:00 a.m. ET BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq:FPAY) (“FlexShopper” or the “Company”), a leading national online lease-to-own (“LTO”) retailer and LTO payment solution provider, announced today that it intends to release its financial results for its fourth quarter and year ended December 31, 2021 after the market closes on Wednesday, March 30, 2022. The Company intends to hold a conference call to discuss those results the next day, March 31 at 9:00 a.m. Eastern Time. Conference Call DetailsDate:    Thursday, March 31, 2022Time:    9:00 a.m. Eastern Time     Participant Dial-In Numbers:  Domestic callers:    877-407-3944International callers:    412-902-0038Access by Webcast The call will also be simultaneously...

HOUSTON, March 28, 2022 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY), the leading global foodservice distribution company, announced today that it will hold its first Supplier Diversity Summit on May 25, 2022. As the premiere foodservice industry partner, Sysco’s senior leadership team will provide updates on the company’s business and DEI strategy, as well as insight into programs such as its new Mentorship Program that assist diverse suppliers in how to do business with Sysco. The summit will also feature a special recognition event for Sysco’s top diverse supplier partners. In addition, Sysco will hold virtual match-making sessions with both direct and indirect suppliers. These interactive sessions will help the company identify and engage suppliers that provide products and services to the foodservice industry and are at...

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics and contract research, today announced that it has granted 5,099,999 compensation stock options (the “Options”) and 3,000,000 restricted share units (the “RSUs”) to certain directors, officers, employees, advisors, and consultants of the Company. The Options shall vest immediately and be exercisable into common shares at a price of $0.215 per Option for a period of 5 years from issuance. The RSUs are subject to future vesting with one quarter vesting at each of 3, 6, 9, and 12 months from the date of issuance and shall be exercisable for...

GUANGZHOU, China, March 28, 2022 (GLOBE NEWSWIRE) — The board of directors (the “Board”) of Fanhua Inc. (“Fanhua” or “the Company”) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that Mr. Lichong Liu (“Mr. Liu”) has been appointed as the vice president and chief operating officer (“COO”) of the Company to oversee corporate operations, and that Mr. Jun Li (“Mr. Li”) has been appointed as the vice president and chief digital officer (“CDO”) of the Company to accelerate the Company’s digital transformation, effective immediately. Mr. Lichong Liu joined Fanhua in 2006, and has previously served in various leadership positions including chairman and chief executive officer of Fanhua Insurance Sales Service Group Company Limited, the onshore holding company of Fanhua’s main operating entities,...